ANEMIA AND CHRONIC INFLAMMATORY BOWEL DISEASE

Despite its high frequency and its significant impact on the cognitive functions and quality of life of patients with inflammatory bowel diseases, anemia has long been neglected and sometimes incorrectly treated. Screening people at risk and prescribing preventive and effective treatment will certainly change their prognosis.Through a literature review and personal experience, the objectives of this work are:- specify the characteristics of anemia in patients with IBD;- detail the factors associated with the occurrence of anemia and its persistence in patients with IBD.

Autorentext

Mona BOUDABBOUS ist außerordentliche Professorin für Hepato-Gastroenterologie an der medizinischen Fakultät von Sfax (Universität Sfax) und an der Abteilung für Hepato-Gastroenterologie des Hédi-Chaker-Krankenhauses in Sfax, Tunesien. Sie verfügt über einen Forschungs-Master-Abschluss in klinischer Medizin und einen DIU in Verdauungsfunktionserkundungen, IBD und Gesundheitsmanagement.